Literature DB >> 2550023

Induction of neutralizing antibodies to transmissible gastroenteritis virus by anti-idiotypic antibodies.

K Hariharan1, S Srikumaran, R A Moxley, F A Osorio, A A Morales.   

Abstract

The potential of anti-idiotypic antibodies (anti-ids) as immunogens against transmissible gastroenteritis virus (TGEV) was tested in a heterologous system. A month-old pig was immunized with a neutralizing murine monoclonal antibody (MAb, 5A5) of the IgG2a isotype, specific for the E2 glycoprotein of TGEV. The anti-ids were isolated from the serum of the immunized pig by affinity chromatography, initially on a 5A5-Sepharose column, followed by repeated adsorption on a mouse IgG2a column. The swine anti-ids thus obtained bound to the MAb 5A5 (the idiotype), but not to MAbs of the same isotype IgG2a but of different idiotypes. The anti-ids also inhibited the binding of 5A5 to TGEV in a concentration-dependent manner. Mice immunized with the anti-ids produced antibodies to TGEV. These antibodies, neutralized TGEV in vitro and inhibited the binding of 5A5 to TGEV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550023     DOI: 10.1089/vim.1989.2.133

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  3 in total

1.  A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies.

Authors:  C Suñé; C Smerdou; I M Antón; P Abril; J Plana; L Enjuanes
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Anti-idiotypic antibodies induce neutralizing antibodies to bovine herpesvirus 1.

Authors:  S Srikumaran; D V Onisk; M V Borca; C Nataraj; T J Zamb
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 3.  Moloney leukemia virus-induced cell surface antigen mimicry by monoclonal antibodies.

Authors:  J G Baskin; T J Powell; R V Srinivas; M Elliott; E W Lamon
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.